AHA Letter to Biden-Harris Transition Team on Price Transparency Rule

AHA requests the Biden Administration exercise enforcement discretion with respect to compliance with the Centers for Medicare & Medicaid Services’ hospital price transparency final rule requiring hospitals to make public, effective Jan. 1, 2021, all of the rates they negotiate with commercial health insurers.

Key Resources

Related Resources

Letter/Comment
AHA Comments on the CMS’ Proposed Updates to Certain Rules Governing the Health Insurance Markets
Public
The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W., Room…
Advisory
Regulatory Advisory: Home Health PPS Proposed CY 2022 Rule
Member
On June 28, the Centers for Medicare…
Special Bulletin
CMS Releases CY 2022 Proposed Rule for Physician Fee Schedule Payments
Public
The Centers for Medicare…
Special Bulletin
Agencies Issue Part One of Regulations Banning Surprise Medical Bills
Public
The Office of Personnel Management, along with the departments of Health and Human Services (HHS), Labor, and Treasury July 1 released “Part 1” of…
Advisory
OSHA Interim Final Rule: COVID-19 Health Care Emergency Temporary Standard
Public
The Occupational Safety and Health Administration (OSHA) June 21 published in the Federal Register an emergency temporary standard (ETS) for occupational…
Letter/Comment
AHA Expresses Support for Drug-Price Transparency for Consumers Act
Public
Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to…